Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07RVX
|
|||
| Former ID |
DNC002251
|
|||
| Drug Name |
ISIS 103471
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DUSP9 messenger RNA (DUSP9 mRNA) | Target Info | . | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Signaling pathways regulating pluripotency of stem cells | ||||
| NetPath Pathway | FSH Signaling Pathway | |||
| IL2 Signaling Pathway | ||||
| Reactome | RAF-independent MAPK1/3 activation | |||
| Negative regulation of MAPK pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,566,133, Antisense inhibition of dual specific phosphatase 9 expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.